Bu sayfada
01LLY fiyat
02Anlık Görüntü
03Grafik
04Hisse bölünmeleri
05Hakkında
06Performans
07Değerleme ve oranlar
13Temettüler
14Kazançlar
15Tüm Temeller
16Finansal Tablolar
17Kurumsal Sahipler (13F)
18Aktivistler ve %5+ sahipler
19Şirket yöneticileri
20ETF sahipliği
21Konsensüs
22Akranlar
23Haberler
25İşlem Sinyalleri
26Metriklerim
LLY Eli Lilly and Company Common Stock
NYSE · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$1142,85
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$783,8552 haftanın en düşüğü
$1292,6552 haftanın en yükseği
P/E (TTM)
38.4
Hisse Başına Kâr (TTM)
$29.80
Gelir (TTM)
$79.67B
rozetleriniz
52 Haftlık Aralık
$784–$1293
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$1329
P/E
38.4
ROE
102.4%
Net Kâr Marjı
33.5%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
LLY Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1142.85
P/E (TTM)
38.4
Hisse Başına Kâr (TTM)
$29.80
Gelir (TTM)
$79.67B
ROE (TTM)
102.4%
D/E Borç/Özsermaye (MRQ)
1.4
52 Haftlık Aralık
$784–$1293
LLY Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 16 Ekim 1997 | 2-for-1 | İleri |
| 21 Aralık 1995 | 2-for-1 | İleri |
| 01 Mayıs 1989 | 2-for-1 | İleri |
| 30 Ocak 1986 | 2-for-1 | İleri |
Eli Lilly and Company Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Eli Lilly and Company, Amerika Birleşik Devletleri merkezli bir ilaç şirketidir. Şirket, 1876 yılında Eli Lilly tarafından kurulmuş olup 18 ülkede ofisi bulunmakta ve yaklaşık 125 ülkede faaliyet göstermektedir. Şirketin merkezi Indianapolis'te yer almaktadır.
Lilly, çocuk felci aşısı ve insülini kitlesel olarak üreten ilk şirket olma özelliğine sahiptir. Günümüzde ise en büyük psikiyatrik ilaç üreticisidir. Şirket, Fortune 500'de yer alan 132. büyük şirkettir.
Kaynakça
Dış bağlantılar
Resmî site
Kaynak: Wikipedia, CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealthcare
endüstriPharmaceuticals
çalışanlar50.000
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$65.18B2016-12-31 → 2025-12-31
Hisse Başına Kâr$22.952016-12-31 → 2025-12-31
Net kar marjı33.5%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | LLY | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 38.45Y ort. ≈62.3 | ≈62.3 | 31.0 | Aşırı değerli | |
| PEG Ratio (PEG Oranı) | ≈1.4 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | LLY | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| EBITDA Margin (FAVÖK Marjı) | 3.1%5Y ort. ≈4.5% | ≈4.5% | 8.3% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | 42.2%5Y ort. ≈26.5% | ≈26.5% | 15.0% | En üst düzey | |
| Net Kâr Marjı (TTM) | 33.5%5Y ort. ≈22.4% | ≈22.4% | 10.4% | En üst düzey | |
| ROA (TTM) | 22.0%5Y ort. ≈14.0% | ≈14.0% | 9.8% | En üst düzey | |
| ROE (TTM) | 102.4%5Y ort. ≈75.0% | ≈75.0% | 25.3% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | LLY | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 1.45Y ort. ≈1.9 | ≈1.9 | 0.9 | Yüksek borç | |
| Cari Oran (MRQ) | 1.45Y ort. ≈1.2 | ≈1.2 | 1.6 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.75Y ort. ≈0.6 | ≈0.6 | 0.8 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 1.45Y ort. ≈1.7 | ≈1.7 | 0.9 | Yüksek borç |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | LLY | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 44.7%5Y ort. ≈22.5% | ≈22.5% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 31.7%5Y ort. ≈20.0% | ≈20.0% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 21.6% | · | · | · | |
| EPS YoY (EPS YB) | 96.0%5Y ort. ≈37.0% | ≈37.0% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 94.9%5Y ort. ≈36.6% | ≈36.6% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 49.3%5Y ort. ≈22.8% | ≈22.8% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 27.6% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 49.0%5Y ort. ≈22.4% | ≈22.4% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | 27.2% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | LLY | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.75Y ort. ≈0.6 | ≈0.6 | 0.5 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 1.05Y ort. ≈1.4 | ≈1.4 | 1.5 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 4.55Y ort. ≈4.4 | ≈4.4 | 5.6 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$1.3M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Ödeme Oranı26.1%
Yıllıklaştırılmış Ödeme≈$6.92
5 Yıllık Temettü CAGR≈15.2%
Büyüme Serisi≈11
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Ağu 14, 2026 | $1,73 | USD | ≈0.57% |
| May 15, 2026 | $1,73 | USD | ≈0.64% |
| Şub 13, 2026 | $1,73 | USD | ≈0.60% |
| Kas 14, 2025 | $1,50 | USD | ≈0.59% |
| Ağu 15, 2025 | $1,50 | USD | ≈0.83% |
| May 16, 2025 | $1,50 | USD | ≈0.74% |
| Şub 14, 2025 | $1,50 | USD | ≈0.64% |
| Kas 15, 2024 | $1,30 | USD | ≈0.70% |
| Ağu 15, 2024 | $1,30 | USD | ≈0.54% |
| May 15, 2024 | $1,30 | USD | ≈0.62% |
| Şub 14, 2024 | $1,30 | USD | ≈0.62% |
| Kas 14, 2023 | $1,13 | USD | ≈0.74% |
| Ağu 14, 2023 | $1,13 | USD | ≈0.81% |
| May 12, 2023 | $1,13 | USD | ≈0.97% |
| Şub 14, 2023 | $1,13 | USD | ≈1.2% |
| Kas 14, 2022 | $0,98 | USD | ≈1.1% |
| Ağu 12, 2022 | $0,98 | USD | ≈1.2% |
| May 13, 2022 | $0,98 | USD | ≈1.3% |
| Şub 14, 2022 | $0,98 | USD | ≈1.5% |
| Kas 12, 2021 | $0,85 | USD | ≈1.3% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
20.5%
Sonraki Rapor
Eki 29, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 5, 2026 | $8.38 | $6.07 | 38.1% |
| 31 Mart 2026 | $8.55 | $6.73 | 27.0% | |
| 31 Aralık 2025 | $7.54 | $6.74 | 11.9% | |
| 30 Eylül 2025 | $7.02 | $5.75 | 22.0% | |
| 30 Haziran 2025 | $6.31 | $5.51 | 14.5% | |
| 31 Mart 2025 | $3.34 | $3.05 | 9.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.18B | $45.04B | $34.12B | $28.54B | $28.32B | $24.54B | $22.32B | $21.49B | $19.97B | $21.22B | $19.96B | $19.62B | |
| Cost of Revenue | $11.05B | $8.42B | $7.08B | $6.63B | $7.31B | $5.48B | $4.72B | $4.68B | $4.45B | $5.71B | $5.04B | $4.93B | |
| R&D Expense | · | · | · | $7.19B | $6.93B | $5.98B | $5.59B | $5.05B | $5.10B | $5.31B | $4.80B | $4.73B | |
| SG&A Expense | $11.09B | $8.59B | $7.40B | $6.44B | $6.43B | $6.12B | $6.21B | $5.98B | $5.98B | $6.53B | $6.53B | $6.62B | |
| Interest Expense | · | · | $486M | $332M | $340M | $360M | $401M | $242M | $225M | $185M | $161M | $149M | |
| Interest Income | · | $175M | $174M | $63M | $25M | $33M | $80M | $159M | $166M | $109M | $87M | $121M | |
| Other Non-op | $-571M | $-219M | $97M | $-14M | $51M | $-196M | $-57M | $-12M | $111M | $196M | $342M | $368M | |
| Pretax Income | $25.73B | $12.68B | $6.55B | $6.81B | $6.16B | $7.23B | $5.27B | $3.68B | $2.30B | $3.37B | $2.79B | $3.00B | |
| Income Tax | $5.09B | $2.09B | $1.31B | $562M | $574M | $1.04B | $628M | $530M | $2.39B | $636M | $382M | $610M | |
| Net Income | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B | $6.19B | $8.32B | $3.23B | $-204M | $2.74B | $2.41B | $2.39B | |
| EPS (Basic) | $23.00 | $11.76 | $5.82 | $6.93 | $6.15 | $6.82 | $8.93 | $3.14 | $-0.19 | $2.59 | $2.27 | $2.23 | |
| EPS (Diluted) | $22.95 | $11.71 | $5.80 | $6.90 | $6.12 | $6.79 | $8.89 | $3.13 | $-0.19 | $2.58 | $2.26 | $2.23 | |
| Shares (Basic) | 897,300,000 | 900,600,000 | 900,200,000 | 901,736,000 | 906,963,000 | 907,634,000 | 931,059,000 | 1,027,721,000 | 1,052,023,000 | 1,058,324,000 | 1,061,913,000 | 1,069,932,000 | |
| Shares (Diluted) | 899,300,000 | 904,100,000 | 903,300,000 | 904,619,000 | 911,681,000 | 912,505,000 | 935,684,000 | 1,033,667,000 | 1,052,023,000 | 1,061,825,000 | 1,065,720,000 | 1,074,286,000 | |
| EBITDA | $2.00B | $1.77B | $1.53B | $1.52B | $1.55B | $1.32B | $1.23B | $1.61B | $1.57B | $1.50B | $1.43B | $1.38B |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.27B | $3.27B | $2.82B | $2.07B | $3.82B | $3.66B | $2.34B | $7.32B | $6.54B | $4.58B | $3.67B | $3.87B | |
| Short-term Investments | · | $155M | $109M | $145M | $90M | $24M | $101M | $88M | $1.50B | $1.46B | $785M | $955M | |
| Receivables | $17.76B | $11.01B | $9.09B | $6.90B | $6.67B | $5.88B | $4.55B | $4.59B | $4.55B | $4.03B | $3.51B | $3.23B | |
| Inventory | $13.74B | $7.59B | $5.77B | $4.31B | $3.89B | $3.98B | $3.19B | $3.10B | $4.46B | $3.56B | $3.45B | $2.74B | |
| Prepaid Expense | $14.31B | $8.34B | $5.54B | $2.95B | $2.53B | $2.87B | $2.54B | $2.04B | $1.45B | $735M | $604M | $560M | |
| Other Current Assets | $147M | $266M | $150M | $7M | · | · | · | · | · | · | · | · | |
| Current Assets | $55.63B | $32.74B | $25.73B | $18.03B | $18.45B | $17.46B | $13.71B | $20.55B | $19.20B | $15.10B | $12.57B | $11.93B | |
| PP&E (Net) | $24.68B | $17.10B | $12.91B | $10.14B | $8.99B | $8.68B | $7.87B | $8.00B | $8.83B | $8.25B | $8.05B | $7.96B | |
| PP&E (Gross) | · | $28.89B | $24.01B | $20.38B | $18.96B | $18.25B | $17.03B | $16.66B | $18.09B | $16.78B | $16.66B | $16.03B | |
| Accum. Depreciation | $12.56B | $11.79B | $11.10B | $10.23B | $9.98B | $9.57B | $9.16B | $8.67B | $9.26B | $8.53B | $8.61B | $8.07B | |
| Goodwill | $5.90B | $5.77B | $4.94B | $4.07B | $3.89B | $3.77B | $3.68B | $1.37B | $4.37B | $3.97B | $4.04B | $1.76B | |
| Intangibles | $6.52B | $6.17B | $6.91B | $7.21B | $7.69B | $7.45B | $6.62B | $1.07B | $4.03B | $4.36B | $5.03B | $2.88B | |
| Other Non-current Assets | $6.99B | $5.72B | $4.99B | $4.34B | $4.08B | $3.48B | $2.87B | $1.82B | $1.71B | $1.91B | $2.22B | $1.80B | |
| Total Assets | $112.48B | $78.72B | $64.01B | $49.49B | $48.81B | $46.63B | $39.29B | $43.91B | $44.98B | $38.81B | $35.57B | $36.31B | |
| Accounts Payable | $5.38B | $3.23B | $2.60B | $1.93B | $1.67B | $1.61B | $1.41B | $1.21B | $1.41B | $1.35B | $1.34B | $1.13B | |
| Short-term Debt | $0 | $4.34B | $6.19B | $1.50B | $0 | $0 | $1.49B | $499M | $2.70B | $1.30B | $0 | $2.68B | |
| Current Liabilities | $35.23B | $28.38B | $27.29B | $17.14B | $15.05B | $12.48B | $11.78B | $11.89B | $14.54B | $10.99B | $8.23B | $9.74B | |
| Capital Leases | $1.14B | $971M | $948M | · | · | · | $487M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $87M | $1.73B | $2.10B | $2.19B | $1.31B | · | · | · | · | |
| Other Non-current Liabilities | $3.97B | $3.48B | $2.24B | $1.82B | $1.64B | $1.71B | $1.50B | $1.36B | $1.55B | $2.23B | $1.75B | $2.28B | |
| Long-term Debt | · | $29.47B | $19.10B | $14.82B | $16.74B | $16.35B | $13.64B | · | · | $9.01B | $7.98B | · | |
| Total Debt | $40.87B | $32.86B | $24.51B | $16.24B | $15.35B | $16.59B | $15.31B | $12.14B | $12.64B | $9.67B | $7.97B | $8.05B | |
| Common Stock | $590M | $592M | $594M | $594M | $596M | $598M | $599M | $661M | $688M | $688M | $691M | $695M | |
| Retained Earnings | $24.47B | $13.54B | $10.31B | $10.04B | $8.96B | $7.83B | $4.92B | $11.40B | $13.89B | $16.05B | $16.01B | $16.48B | |
| Treasury Stock | · | $50M | $44M | $50M | $53M | $56M | $61M | $69M | $76M | $80M | $90M | $91M | |
| AOCI | $-2.88B | $-4.32B | $-4.33B | $-3.84B | $-4.34B | $-6.50B | $-6.52B | $-5.73B | $-5.72B | $-5.27B | $-4.58B | $-3.99B | |
| Stockholders' Equity | $26.54B | $14.27B | $10.77B | $10.65B | $8.98B | $5.64B | $2.61B | $9.83B | $11.59B | $14.01B | $14.57B | $15.37B | |
| Liabilities + Equity | $112.48B | $78.72B | $64.01B | $49.49B | $48.81B | $46.63B | $39.29B | $43.91B | $44.98B | $38.81B | $35.57B | $36.31B |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.00B | $1.77B | $1.53B | $1.52B | $1.55B | $1.32B | $1.23B | $1.61B | $1.57B | $1.50B | $1.43B | $1.38B | |
| Stock-based Comp | $626M | $646M | $629M | $371M | $343M | $308M | $312M | $280M | $281M | $255M | $218M | $156M | |
| Deferred Tax | $-1.71B | $-2.68B | $-2.34B | $-2.19B | $-802M | $-134M | $62M | $248M | $-832M | $440M | $-748M | $37M | |
| Amort. of Intangibles | $488M | $553M | $506M | $580M | $629M | $428M | $226M | $361M | $462M | $688M | $632M | $536M | |
| Other Non-cash | $-4.74B | $-1.50B | $-815M | $1.13B | $591M | $-1.19B | $-5.09B | $77M | $4.76B | $-78M | $-533M | $405M | |
| Operating Cash Flow | $16.81B | $8.82B | $4.24B | $7.59B | $7.37B | $6.50B | $4.84B | $5.52B | $5.62B | $4.85B | $2.96B | $4.46B | |
| Investing Cash Flow | $-10.97B | $-9.30B | $-7.15B | $-3.76B | $-2.87B | $-2.26B | $-8.08B | $1.91B | $-3.78B | $-3.14B | $27M | $-3.91B | |
| Debt Issued | $13.17B | $11.42B | $3.96B | $0 | $2.41B | $2.06B | $6.56B | $2.48B | $2.23B | $1.21B | $4.45B | $993M | |
| Net Debt Issued | $12.39B | $10.75B | $3.96B | $-1.56B | $505M | $1.79B | $3.69B | $1.47B | $1.60B | $1.21B | $2.50B | $-42M | |
| Stock Repurchased | $4.11B | $2.50B | $750M | $1.50B | $1.25B | $500M | $4.40B | $4.15B | $300M | $600M | $750M | $800M | |
| Net Stock Activity | $-4.11B | $-2.50B | $-750M | $-1.50B | $-1.25B | $-500M | $-4.40B | $-4.15B | $-300M | $-600M | $-750M | $-800M | |
| Dividends Paid | $5.38B | $4.68B | $4.07B | $3.54B | $3.09B | $2.69B | $2.41B | $2.31B | $2.19B | $2.16B | $2.13B | $2.10B | |
| Financing Cash Flow | $-2.21B | $1.23B | $3.50B | $-5.41B | $-4.13B | $-3.14B | $-2.32B | $-5.90B | $143M | $-560M | $-3.11B | $-166M | |
| Net Change in Cash | $4.00B | $449M | $752M | $-1.75B | $161M | $1.32B | $-5.66B | $1.46B | $1.95B | $916M | $-205M | $41M | |
| Taxes Paid | $10.81B | $6.56B | $5.56B | · | · | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 31.7% | 23.5% | 15.4% | 21.9% | 19.7% | 25.2% | 37.3% | 13.2% | -0.89% | 12.9% | 12.1% | 12.2% | |
| Pretax Margin | 39.5% | 28.1% | 19.2% | 23.8% | 21.7% | 29.5% | 23.6% | 15.5% | 9.6% | 15.9% | 14.0% | 15.3% | |
| EBITDA Margin | 3.1% | 3.9% | 4.5% | 5.3% | 5.5% | 5.4% | 5.5% | 6.6% | 6.9% | 7.0% | 7.1% | 7.0% | |
| ROA | 21.6% | 14.8% | 9.2% | 12.7% | 11.7% | 14.4% | 20.0% | 7.3% | -0.49% | 7.4% | 6.7% | 6.6% | |
| ROE | 101.2% | 84.8% | 48.9% | 63.6% | 76.3% | 150.2% | 133.8% | 30.2% | -1.6% | 19.2% | 16.1% | 14.5% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.2 | 0.9 | 1.1 | 1.2 | 1.4 | 1.2 | 1.7 | 1.3 | 1.4 | 1.5 | 1.1 | |
| Quick Ratio | 0.7 | 0.5 | 0.4 | 0.5 | 0.7 | 0.8 | 0.6 | 1.1 | 0.9 | 0.9 | 1.0 | 0.7 | |
| Debt / Equity | 1.5 | 2.3 | 2.3 | 1.5 | 1.7 | 2.9 | 5.9 | 1.2 | 1.1 | 0.7 | 0.5 | 0.5 | |
| LT Debt / Equity | 1.5 | 2.0 | 1.7 | 1.4 | 1.7 | 2.9 | 5.3 | 1.2 | 0.9 | 0.6 | 0.5 | 0.3 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.5 | |
| Inventory Turnover | 1.0 | 1.3 | 1.4 | 1.6 | 1.9 | 1.5 | 1.5 | 1.5 | 1.5 | 1.6 | 1.6 | 1.7 | |
| Receivables Turnover | 4.5 | 4.5 | 4.3 | 4.2 | 4.5 | 4.7 | 4.9 | 5.0 | 5.3 | 5.6 | 5.9 | 5.9 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $72.48 | $49.82 | $37.78 | $31.55 | $31.06 | $26.89 | $23.85 | $23.76 | $21.74 | $19.99 | $18.73 | $18.26 | |
| Cash Flow / Share | $18.70 | $9.75 | $4.69 | $7.83 | $7.96 | $7.12 | $5.17 | $5.34 | $5.34 | $4.57 | $2.60 | $4.07 | |
| Dividend / Share | $6.23 | $5.40 | $4.69 | $4.07 | $3.53 | $3.07 | $2.68 | $2.33 | $2.12 | $2.05 | · | · | |
| EPS (TTM) | $22.95 | $11.71 | $5.80 | $6.90 | $6.12 | $6.79 | $8.89 | $3.13 | $-0.19 | $2.58 | $2.26 | $2.23 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 44.7% | 32.0% | 19.6% | 0.79% | 15.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 31.7% | 16.7% | 11.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 21.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 96.0% | 101.9% | -15.9% | 12.8% | -9.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 49.3% | 24.1% | -5.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 27.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 94.9% | 102.1% | -16.1% | 11.9% | -9.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 49.0% | 23.8% | -5.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 27.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 14.9% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $65.18B | $45.04B | $34.12B | $28.54B | $28.32B | $24.54B | $22.32B | $21.49B | $19.97B | $21.22B | $19.96B | $19.62B | |
| Net Income TTM | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B | $6.19B | $8.32B | $3.23B | $-204M | $2.74B | $2.41B | $2.39B | |
| P/E | 46.8 | 65.9 | 100.5 | 53.0 | 45.1 | 24.9 | 14.8 | 37.0 | -444.5 | 28.5 | 37.3 | 30.9 | |
| Earnings Yield | 2.1% | 1.5% | 0.99% | 1.9% | 2.2% | 4.0% | 6.8% | 2.7% | -0.22% | 3.5% | 2.7% | 3.2% | |
| Payout Ratio | 26.1% | 44.2% | 77.6% | 56.6% | 55.3% | 43.4% | 29.0% | 71.5% | -1074.0% | 78.8% | 88.3% | 87.9% | |
| Annual Payout | $5.38B | $4.68B | $4.07B | $3.54B | $3.09B | $2.69B | $2.41B | $2.31B | $2.19B | $2.16B | $2.13B | $2.10B |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.97B | $19.80B | $19.29B | $17.60B | $15.56B | $12.73B | $13.53B | $11.44B | $11.30B | $8.77B | $9.35B | $9.50B | $8.31B | $6.96B | $7.30B | $6.94B | |
| Cost of Revenue | $3.27B | $3.58B | $3.37B | $3.01B | $2.45B | $2.23B | $2.40B | $2.17B | $2.17B | $1.67B | $1.79B | $1.86B | $1.81B | $1.63B | $1.55B | $1.58B | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | $2.36B | $1.99B | · | $1.80B | |
| SG&A Expense | $3.43B | $2.93B | $3.13B | $2.74B | $2.75B | $2.47B | $2.42B | $2.10B | $2.12B | $1.95B | $1.93B | $1.80B | $1.93B | $1.75B | $1.64B | $1.61B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $180M | · | $125M | $120M | $103M | · | $82M | |
| Interest Income | · | · | · | $65M | $40M | $48M | · | $48M | $37M | $46M | · | $49M | $46M | $34M | $26M | $20M | |
| Other Non-op | $269M | $-65M | $-287M | $-179M | $-90M | $-239M | $-219M | $-21M | $-8M | $29M | $108M | $-100.0K | $-13M | $2M | $-31M | $-19M | |
| Pretax Income | $9.25B | $8.85B | $8.27B | $7.23B | $6.78B | $3.46B | $5.04B | $1.59B | $3.52B | $2.54B | $2.51B | $427M | $2.09B | $1.53B | $2.10B | $1.57B | |
| Income Tax | $2.15B | $1.45B | $1.63B | $1.65B | $1.12B | $697M | $628M | $618M | $550M | $293M | $319M | $485M | $326M | $185M | $159M | $114M | |
| Net Income | $7.09B | $7.40B | $6.64B | $5.58B | $5.66B | $2.76B | $4.41B | $970M | $2.97B | $2.24B | $2.19B | $-57M | $1.76B | $1.34B | $1.94B | $1.45B | |
| EPS (Basic) | $7.95 | $8.27 | $7.41 | $6.22 | $6.30 | $3.07 | $4.90 | $1.08 | $3.29 | $2.49 | $2.43 | $-0.06 | $1.96 | $1.49 | $2.15 | $1.61 | |
| EPS (Diluted) | $7.94 | $8.26 | $7.39 | $6.21 | $6.29 | $3.06 | $4.88 | $1.07 | $3.28 | $2.48 | $2.42 | $-0.06 | $1.95 | $1.49 | $2.14 | $1.61 | |
| Shares (Basic) | 892,400,000 | 894,500,000 | · | 896,900,000 | 897,900,000 | 898,700,000 | · | 901,000,000 | 900,900,000 | 900,800,000 | · | 899,800,000 | 899,700,000 | 901,000,000 | · | 900,700,000 | |
| Shares (Diluted) | 893,700,000 | 895,900,000 | · | 898,800,000 | 899,800,000 | 900,600,000 | · | 905,000,000 | 904,200,000 | 903,800,000 | · | 899,800,000 | 902,700,000 | 903,300,000 | · | 903,800,000 | |
| EBITDA | · | $509M | · | · | · | $463M | · | · | · | $401M | · | · | · | $362M | · | · |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.95B | $5.28B | $7.27B | $9.79B | $3.38B | $3.09B | $3.27B | $3.37B | $3.22B | $2.46B | · | $2.38B | $2.69B | $3.55B | · | $2.62B | |
| Short-term Investments | · | · | · | $122M | $170M | $127M | · | $149M | $140M | $126M | · | $113M | $135M | $123M | · | $125M | |
| Receivables | $20.08B | $18.43B | $17.76B | $16.11B | $14.17B | $12.04B | $11.01B | $10.29B | $11.03B | $7.89B | · | $8.17B | $7.52B | $7.53B | · | $6.72B | |
| Inventory | $16.79B | $14.53B | $13.74B | $12.18B | $11.01B | $9.31B | $7.59B | $7.46B | $6.48B | $6.10B | · | $4.90B | $4.80B | $4.54B | · | $3.83B | |
| Prepaid Expense | $15.37B | $13.63B | $14.31B | $20.25B | $18.02B | $14.65B | $8.34B | $8.25B | $7.14B | $6.35B | · | $5.25B | $4.53B | $3.58B | · | $2.74B | |
| Other Current Assets | $86M | $214M | $147M | $272M | $69M | $72M | $266M | $135M | $142M | $139M | · | · | · | · | · | · | |
| Current Assets | $64.67B | $54.84B | $55.63B | $62.07B | $49.85B | $41.26B | $32.74B | $31.42B | $30.20B | $25.19B | · | $23.01B | $21.33B | $20.81B | · | $17.64B | |
| PP&E (Net) | $29.29B | $26.54B | $24.68B | $22.32B | $20.53B | $18.47B | $17.10B | $16.17B | $14.83B | $13.62B | · | $11.86B | $11.28B | $10.55B | · | $9.31B | |
| Accum. Depreciation | $13.10B | · | $12.56B | $12.41B | $12.55B | $12.15B | $11.79B | $11.82B | $11.43B | $11.23B | · | $10.77B | $10.63B | $10.49B | · | $10.07B | |
| Goodwill | $8.85B | $6.13B | $5.90B | $5.90B | $5.77B | $5.77B | $5.77B | $5.77B | $5.77B | $4.94B | · | $4.09B | $4.08B | $4.07B | · | $3.89B | |
| Intangibles | $18.11B | $7.37B | $6.52B | $6.45B | $5.91B | $6.01B | $6.17B | $6.54B | $6.64B | $6.76B | · | $6.78B | $6.90B | $7.09B | · | $7.12B | |
| Other Non-current Assets | $7.48B | $7.23B | $6.99B | $6.43B | $6.23B | $6.07B | $5.72B | $5.12B | $4.90B | $4.71B | · | $4.91B | $4.67B | $4.49B | · | $4.54B | |
| Total Assets | $142.28B | $116.58B | $112.48B | $114.94B | $100.92B | $89.39B | $78.72B | $75.61B | $71.87B | $63.94B | · | $57.92B | $54.81B | $53.16B | · | $47.46B | |
| Accounts Payable | $6.11B | $5.03B | $5.38B | $4.26B | $4.08B | $3.44B | $3.23B | $2.89B | $2.92B | $2.47B | · | $2.44B | $2.47B | $2.02B | · | $1.68B | |
| Short-term Debt | · | · | $0 | · | · | · | $4.34B | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $47.74B | $36.63B | $35.23B | $40.14B | $39.02B | $30.07B | $28.38B | $24.67B | $27.12B | $18.60B | · | $22.00B | $18.91B | $16.01B | · | $15.65B | |
| Capital Leases | · | · | $1.14B | · | · | · | $971M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $172M | |
| Other Non-current Liabilities | $7.34B | $4.08B | $3.97B | $3.78B | $2.34B | $2.29B | $3.48B | $2.24B | $2.47B | $2.27B | · | $1.91B | $1.95B | $1.82B | · | $1.85B | |
| Total Debt | $47.86B | $39.37B | · | $40.87B | $34.18B | $34.50B | · | $29.05B | $23.73B | $24.56B | · | $17.92B | $18.16B | $18.88B | · | $14.14B | |
| Common Stock | $588M | $590M | $590M | $591M | $592M | $593M | $592M | $594M | $594M | $594M | · | $594M | $594M | $594M | · | $594M | |
| Retained Earnings | $31.89B | $29.51B | $24.47B | $22.25B | $17.38B | $15.10B | $13.54B | $13.63B | $13.18B | $12.55B | · | $10.31B | $10.37B | $10.64B | · | $10.01B | |
| Treasury Stock | · | · | · | $62M | $55M | $50M | · | $33M | $33M | $33M | · | $45M | $45M | $45M | · | $50M | |
| AOCI | $-2.76B | $-2.83B | $-2.88B | $-3.21B | $-3.72B | $-3.77B | $-4.32B | $-4.27B | $-4.38B | $-4.30B | · | $-3.78B | $-3.79B | $-3.78B | · | $-4.30B | |
| Stockholders' Equity | $33.88B | $31.20B | $26.54B | $23.79B | $18.27B | $15.76B | $14.27B | $14.24B | $13.56B | $12.81B | · | $11.22B | $11.06B | $11.19B | · | $10.07B | |
| Liabilities + Equity | $142.28B | $116.58B | $112.48B | $114.94B | $100.92B | $89.39B | $78.72B | $75.61B | $71.87B | $63.94B | · | $57.92B | $54.81B | $53.16B | · | $47.46B |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $534M | $509M | $586M | $470M | $478M | $463M | $485M | $467M | $414M | $401M | $387M | $411M | $366M | $362M | $375M | $363M | |
| Stock-based Comp | $201M | $161M | $136M | $151M | $185M | $154M | $142M | $133M | $211M | $159M | $121M | $216M | $162M | $131M | $93M | $85M | |
| Other Non-cash | · | $-2.73B | · | · | · | $-1.71B | · | · | · | $-1.64B | · | · | · | $-108M | · | · | |
| Operating Cash Flow | $10.69B | $5.33B | $3.22B | $8.84B | $3.09B | $1.67B | $2.47B | $3.71B | $1.47B | $1.17B | $-312M | $2.19B | $632M | $1.73B | $1.66B | $2.60B | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $617M | |
| Investing Cash Flow | $-15.40B | $-3.92B | $-2.80B | $-2.98B | $-1.83B | $-3.35B | $-1.92B | $-4.00B | $-2.20B | $-1.18B | $-2.92B | $-3.08B | $-459M | $-689M | $-944M | $-1.34B | |
| Debt Issued | $8.94B | $0 | $-200.0K | $6.71B | $0 | $6.46B | $-100.0K | $4.96B | $0 | $6.45B | $500.0K | $0 | $0 | $3.96B | $0 | $0 | |
| Net Debt Issued | · | $-750M | · | · | · | $6.46B | · | · | · | $6.45B | · | · | · | $3.96B | · | · | |
| Stock Repurchased | $1.60B | $2.36B | $1.51B | $708M | $692M | $1.20B | $2.05B | $446M | $0 | $0 | $0 | $0 | $0 | $750M | $0 | $0 | |
| Net Stock Activity | · | $-2.36B | · | · | · | $-1.20B | · | · | · | $0 | · | · | · | $-750M | · | · | |
| Dividends Paid | $1.55B | $1.55B | $1.35B | $1.35B | $1.35B | $1.35B | $1.17B | $1.17B | $1.17B | $1.17B | $1.02B | $1.02B | $1.02B | $1.02B | $884M | $882M | |
| Financing Cash Flow | $8.43B | $-3.47B | $-2.88B | $531M | $-1.24B | $1.38B | $-226M | $211M | $1.56B | $-311M | $3.55B | $572M | $-1.03B | $412M | $-1.14B | $-1.26B | |
| Net Change in Cash | $3.67B | $-1.99B | $-2.52B | $6.42B | $283M | $-175M | $-101M | $145M | $763M | $-358M | $438M | $-314M | $-851M | $1.48B | $-550M | $-6M |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 30.9% | 37.4% | · | 31.7% | 36.4% | 21.7% | · | 8.5% | 26.2% | 25.6% | · | -0.60% | 21.2% | 19.3% | · | 20.9% | |
| Pretax Margin | 40.2% | 44.7% | · | 41.1% | 43.6% | 27.2% | · | 13.9% | 31.1% | 28.9% | · | 4.5% | 25.1% | 22.0% | · | 22.6% | |
| EBITDA Margin | · | 2.6% | · | · | · | 3.6% | · | · | · | 4.6% | · | · | · | 5.2% | · | · | |
| ROA | 5.8% | 7.2% | · | 5.9% | 6.6% | 3.6% | · | 1.5% | 4.7% | 3.8% | · | -0.11% | 3.5% | 2.7% | · | 3.0% | |
| ROE | 27.2% | 31.5% | · | 29.4% | 35.6% | 19.3% | · | 7.6% | 24.1% | 18.7% | · | -0.54% | 18.0% | 13.1% | · | 16.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.5 | · | 1.5 | 1.3 | 1.4 | · | 1.3 | 1.1 | 1.4 | · | 1.0 | 1.1 | 1.3 | · | 1.1 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | |
| Debt / Equity | 1.4 | 1.3 | · | 1.7 | 1.9 | 2.2 | · | 2.0 | 1.7 | 1.9 | · | 1.6 | 1.6 | 1.7 | · | 1.4 | |
| LT Debt / Equity | 1.4 | 1.3 | · | 1.7 | 1.9 | 2.2 | · | 2.0 | 1.7 | 1.9 | · | 1.6 | 1.6 | 1.7 | · | 1.4 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.2 | 1.3 | · | 1.2 | 1.2 | 1.1 | · | 1.3 | 1.2 | 1.0 | · | 1.1 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $25.71 | $22.10 | · | $19.58 | $17.29 | $14.13 | · | $12.64 | $12.50 | $9.70 | · | $10.56 | $9.21 | $7.71 | · | $7.68 | |
| Cash Flow / Share | · | $5.95 | · | · | · | $1.85 | · | · | · | $1.29 | · | · | · | $1.92 | · | · | |
| Dividend / Share | $3.46 | · | $3.23 | $0.00 | $3.00 | · | $2.80 | $0.00 | $2.60 | · | $2.43 | $0.00 | $2.26 | · | $2.11 | $0.00 | |
| EPS (TTM) | $29.80 | $28.15 | · | $20.44 | $15.30 | $12.29 | · | $9.25 | $8.12 | $6.79 | · | $5.52 | $7.19 | $6.29 | · | $6.64 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $79.67B | $72.25B | · | $59.42B | $53.26B | $49.00B | · | $40.86B | $38.92B | $35.93B | · | $32.07B | $29.52B | $27.69B | · | $29.24B | |
| Net Income TTM | $26.71B | $25.28B | · | $18.41B | $13.80B | $11.11B | · | $8.37B | $7.34B | $6.14B | · | $4.99B | $6.50B | $5.69B | · | $6.03B | |
| P/E | 40.2 | 32.7 | · | 37.3 | 50.9 | 67.2 | · | 95.8 | 111.5 | 114.6 | · | 97.3 | 65.2 | 54.6 | · | 48.7 | |
| Earnings Yield | 2.5% | 3.1% | · | 2.7% | 2.0% | 1.5% | · | 1.0% | 0.90% | 0.87% | · | 1.0% | 1.5% | 1.8% | · | 2.1% | |
| Payout Ratio | · | 20.9% | · | · | · | 48.8% | · | · | · | 52.1% | · | · | · | 75.6% | · | · | |
| Annual Payout | $5.78B | $5.59B | · | $5.21B | $5.03B | $4.86B | · | $4.53B | $4.38B | $4.22B | · | $3.94B | $3.80B | $3.67B | · | $3.42B |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $65.18B | $45.04B | $34.12B | $28.54B | $28.32B |
| Net Gelir | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B |
| Seyreltilmiş Hisse Başı Kâr | $22.95 | $11.71 | $5.80 | $6.90 | $6.12 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 1.5 | 2.3 | 2.3 | 1.5 | 1.7 |
| Cari Oran | 1.6 | 1.2 | 0.9 | 1.1 | 1.2 |
| Cari Oran | 0.7 | 0.5 | 0.4 | 0.5 | 0.7 |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 5.020 dosya · $1.0T toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
5.020
Tutulan Değer
$1.0T
Yeni pozisyonlar
383
Çıkan pozisyonlar
88
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 383 (+88 önceki Ç'ye göre) | 88 (-137 önceki Ç'ye göre) | 2.222 (+272 önceki Ç'ye göre) | 1.513 (-226 önceki Ç'ye göre) | +13.1M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| LILLY ENDOWMENT INC | $108.400.858.723 | 90.376.978 | 10,44% | Hisse senetleri |
| VANGUARD GROUP INC | $88.087.192.938 | 81.965.974 | 8,48% | Hisse senetleri |
| BlackRock, Inc. | $81.009.980.560 | 67.540.400 | 7,80% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $64.204.130.146 | 53.528.868 | 6,18% | Hisse senetleri |
| PNC Financial Services Group, Inc. | $61.558.009.786 | 51.322.720 | 5,93% | Hisse senetleri |
| STATE STREET CORP | $43.438.261.820 | 36.215.754 | 4,18% | Hisse senetleri |
| FMR LLC | $34.138.746.040 | 28.462.475 | 3,29% | Hisse senetleri |
| Capital Research Global Investors | $25.037.481.632 | 20.873.140 | 2,41% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $25.019.170.646 | 20.859.217 | 2,41% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $24.275.623.749 | 20.310.858 | 2,34% | Hisse senetleri |
| MORGAN STANLEY | $19.462.430.096 | 16.226.398 | 1,87% | Hisse senetleri |
| Capital World Investors | $19.076.022.904 | 15.902.642 | 1,84% | Hisse senetleri |
| JPMORGAN CHASE & CO | $15.495.304.587 | 12.598.524 | 1,49% | Hisse senetleri |
| NORGES BANK | $13.759.156.895 | 11.471.413 | 1,33% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $13.522.666.239 | 11.274.243 | 1,30% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $13.192.474.197 | 10.998.953 | 1,27% | Hisse senetleri |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $12.904.892.863 | 10.759.188 | 1,24% | Hisse senetleri |
| PRIMECAP MANAGEMENT CO/CA/ | $11.002.256.246 | 9.172.904 | 1,06% | Hisse senetleri |
| NORTHERN TRUST CORP | $10.551.224.985 | 8.796.866 | 1,02% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $9.179.190.285 | 7.652.960 | 0,88% | Hisse senetleri |
| UBS Group AG | $8.756.297.182 | 7.300.382 | 0,84% | Alım opsiyonu |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.198.924.886 | 6.001.955 | 0,69% | Hisse senetleri |
| Capital International Investors | $6.879.841.625 | 5.734.768 | 0,66% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $6.550.586.781 | 5.461.416 | 0,63% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $6.504.632.755 | 7.072.021 | 0,63% | Hisse senetleri |
| Legal & General Group Plc | $6.171.342.026 | 5.145.229 | 0,59% | Hisse senetleri |
| Fisher Asset Management, LLC | $6.073.333.633 | 5.063.516 | 0,58% | Hisse senetleri |
| Nuveen, LLC | $6.070.926.419 | 5.061.510 | 0,58% | Hisse senetleri |
| Amundi | $5.767.032.956 | 4.808.143 | 0,56% | Hisse senetleri |
| Bank of New York Mellon Corp | $5.737.424.031 | 4.783.459 | 0,55% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $5.572.694.209 | 4.646.119 | 0,54% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $5.508.155.583 | 4.592.311 | 0,53% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $5.505.649.038 | 4.590.218 | 0,53% | Hisse senetleri |
| ROYAL BANK OF CANADA | $5.227.598.000 | 4.358.401 | 0,50% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $4.802.407.409 | 4.003.417 | 0,46% | Hisse senetleri |
| UBS Group AG | $4.636.913.621 | 3.865.931 | 0,45% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.521.251.385 | 3.769.500 | 0,44% | Alım opsiyonu |
| Invesco Ltd. | $4.430.876.769 | 3.694.152 | 0,43% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $4.053.626.013 | 3.379.627 | 0,39% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $3.982.443.487 | 4.347.394 | 0,38% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $3.916.450.563 | 4.258.076 | 0,38% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.853.408.761 | 3.212.700 | 0,37% | Satım opsiyonu |
| AMERIPRISE FINANCIAL INC | $3.596.399.744 | 2.996.669 | 0,35% | Hisse senetleri |
| JANE STREET GROUP, LLC | $3.018.245.652 | 2.516.400 | 0,29% | Satım opsiyonu |
| AMERICAN CENTURY COMPANIES INC | $2.824.462.145 | 2.354.837 | 0,27% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.817.700.956 | 2.349.200 | 0,27% | Satım opsiyonu |
| Swiss National Bank | $2.716.888.865 | 2.265.150 | 0,26% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $2.568.591.611 | 2.141.447 | 0,25% | Hisse senetleri |
| JANE STREET GROUP, LLC | $2.536.674.507 | 2.114.900 | 0,24% | Alım opsiyonu |
| Mitsubishi UFJ Asset Management Co., Ltd. | $2.415.287.393 | 2.013.696 | 0,23% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| ELI LILLY AND COMPANY, SHENANDOAH ACQUISITION CORPORATION ×15 başvurular | 14 Ağustos 2023 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 84 içeriden öğrenenler · 50 yöneticiler · 30 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| David A Ricks | President, Chair, and CEO | 09 Şubat 2026 A | 571.715 | 0 | 0 | $0 |
| Lucas Montarce | EVP & CFO | 16 Şubat 2026 M | 16.258 | 0 | 0 | $0 |
| Anat Ashkenazi | EVP & CFO | 12 Şubat 2024 A | 42.330 | 0 | 0 | $0 |
| Derica W Rice | EVP-Global Services and CFO | 01 Şubat 2017 M | 38.292 | 0 | 0 | $0 |
| Charles E Golden | Exec. Vice President and CFO | 28 Nisan 2006 F | 85.249 | 0 | 0 | $0 |
| Maria A Crowe | President, Mfg. Operations | 01 Şubat 2017 M | 113.581 | 0 | 0 | $0 |
| Frank M Deane | President, Mfg. Operations | 01 Şubat 2012 M | 33.995 | 0 | 0 | $0 |
| Deirdre P Connelly | President, U.S. Operations | 27 Ocak 2009 A | 53.681 | 0 | 0 | $0 |
| Lorenzo Tallarigo | President, Internat'l Opers. | 31 Mart 2008 F | 64.458 | 0 | 0 | $0 |
| Scott A Canute | President, Mfg. Operations | 01 Şubat 2007 F | 25.367 | 0 | 0 | $0 |
| Melissa Seymour | EVP, Global Quality | 09 Eylül 2026 G | 1.038 | 0 | 0 | $0 |
| Eric Dozier | EVP, Chief People Officer | 02 Eylül 2026 G | 14.239 | 0 | 0 | $0 |
| Edgardo Hernandez | EVP & Pres., Mfg. Operations | 02 Eylül 2026 G | 46.083 | 0 | 0 | $0 |
| Patrik Jonsson | EVP & President, LLY Int'l | 17 Ağustos 2026 S | 54.147 | 0 | 1 | $-7.638.150 |
| Anat Hakim | EVP, GC & Secretary | 07 Ağustos 2026 S | 11.875 | 0 | 1 | $-5.950.000 |
| Ilya Yuffa | EVP&Pres, LLY USA&Global Capab | 10 Haziran 2026 S | 29.804 | 0 | 1 | $-2.876.925 |
| Adrienne S Brown | EVP, President LLY Imm | 16 Şubat 2026 M | 5.142 | 0 | 0 | $0 |
| Kenneth L. Custer | EVP & President, Card Met Hlth | 16 Şubat 2026 M | 10.141 | 0 | 0 | $0 |
| Diogo Rau | EVP & CIDO | 09 Şubat 2026 A | 26.397 | 0 | 0 | $0 |
| Daniel Skovronsky | EVP, CS&PO & Pres. LRL | 09 Şubat 2026 A | 160.072 | 0 | 0 | $0 |
| Jacob Van Naarden | EVP,Pres LLY Oncology&HdCorpBD | 09 Şubat 2026 A | 26.626 | 0 | 0 | $0 |
| Anne E. White | EVP & Pres, Lilly Neuroscience | 10 Şubat 2025 A | 74.210 | 0 | 0 | $0 |
| Johna Norton | EVP, Global Quality | 03 Haziran 2024 S | 25.428 | 0 | 0 | $0 |
| Alonzo Weems | EVP, ERM & CECO | 12 Şubat 2024 A | 7.951 | 0 | 0 | $0 |
| Michael B Mason | EVP & Pres., Lilly Diabetes | 10 Şubat 2023 A | 39.284 | 0 | 0 | $0 |
| Leigh Ann Pusey | EVP, Corp. Affairs & Comm. | 10 Şubat 2023 A | 31.641 | 0 | 0 | $0 |
| Stephen F Fry | SVP, HR & Diversity | 09 Şubat 2022 A | 152.631 | 0 | 0 | $0 |
| Myles O'Neill | SVP & Pres., Mfg. Operations | 08 Şubat 2021 A | 72.533 | 0 | 0 | $0 |
| Alfonso G Zulueta | SVP & President, Lilly Int'l | 08 Şubat 2021 A | 56.947 | 0 | 0 | $0 |
| Melissa S Barnes | Chief Eth/Cmpl Ofcr & SVP, ERM | 08 Şubat 2021 A | 34.616 | 0 | 0 | $0 |
| Michael J Harrington | Senior VP and General Counsel | 02 Ocak 2020 A | 59.500 | 0 | 0 | $0 |
| Christi Shaw | SVP and Pres., Lilly Bio-Meds | 03 Mayıs 2019 S | 500 | 0 | 0 | $0 |
| Enrique A Conterno | SVP&Pres, LillyDiab & LillyUSA | 04 Şubat 2019 A | 157.962 | 0 | 0 | $0 |
| Jeffrey N Simmons | SVP&Pres. Elanco Animal Health | 01 Mayıs 2018 M | 135.458 | 0 | 0 | $0 |
| Susan Mahony | SVP & Pres., Lilly Oncology | 16 Nisan 2018 S | 40.685 | 0 | 0 | $0 |
| Jan M Lundberg | EVP,Science&Tech and Pres. LRL | 09 Şubat 2018 A | 198.126 | 0 | 0 | $0 |
| Fionnuala M Walsh | SVP, Global Quality | 01 Şubat 2017 M | 67.144 | 0 | 0 | $0 |
| Barton R Peterson | Sr. VP, Corp. Affairs & Comm. | 01 Şubat 2017 M | 108.312 | 0 | 0 | $0 |
| Jacques Tapiero | SVP&Pres., Emerging Markets | 28 Ocak 2014 A | 55.384 | 0 | 0 | $0 |
| Arnold C Hanish | Chief Accounting Officer | 29 Ağustos 2012 G | 17.611 | 0 | 0 | $0 |
| Bryce D. Carmine | EVP and Pres, Lilly Bio-Meds | 01 Şubat 2012 M | 102.647 | 0 | 0 | $0 |
| Robert A Armitage | Sr. VP and General Counsel | 01 Şubat 2012 M | 97.063 | 0 | 0 | $0 |
| Anne Nobles | Chief Eth/Cmpl Ofcr & SVP, ERM | 26 Ocak 2012 A | 23.536 | 0 | 0 | $0 |
| Steven M Paul | EVP, Science and Technology | 01 Şubat 2010 M | 38.897 | 0 | 0 | $0 |
| Anthony John Murphy | Senior VP, Human Resources | 02 Şubat 2009 F | 15.231 | 0 | 0 | $0 |
| Gino Santini | Sr.VP, Corp. Strategy & BD | 02 Şubat 2009 F | 102.174 | 0 | 0 | $0 |
| Alex M Azar II | Sr. VP, Corp. Affairs & Comm. | 27 Ocak 2009 A | 5.000 | 0 | 0 | $0 |
| Sidney Taurel | Chairman | 31 Aralık 2008 F | 341.806 | 0 | 0 | $0 |
| Gerhard N Mayr | EVP, Pharmaceutical Operations | 17 Şubat 2004 A | · | 0 | 0 | $0 |
| Pedro P Granadillo | Senior Vice President | 17 Şubat 2004 A | · | 0 | 0 | $0 |
| Juan R Luciano | Yönetim kurulu üyesi | 21 Eylül 2026 A | 16.957 | 0 | 0 | $0 |
| Erik J Fyrwald | Yönetim kurulu üyesi | 21 Eylül 2026 A | 75.536 | 0 | 0 | $0 |
| Ralph Alvarez | Yönetim kurulu üyesi | 21 Eylül 2026 A | 55.838 | 0 | 0 | $0 |
| Gabrielle Sulzberger | Yönetim kurulu üyesi | 21 Eylül 2026 A | 3.012 | 0 | 0 | $0 |
| Kimberly H Johnson | Yönetim kurulu üyesi | 17 Kasım 2025 A | 3.265 | 0 | 0 | $0 |
| Jamere Jackson | Yönetim kurulu üyesi | 17 Kasım 2025 A | 9.635 | 0 | 0 | $0 |
| William G Kaelin Jr | Yönetim kurulu üyesi | 17 Kasım 2025 A | 21.837 | 0 | 0 | $0 |
| Katherine Baicker | Yönetim kurulu üyesi | 17 Kasım 2025 A | 23.503 | 0 | 0 | $0 |
| Jon R Moeller | Yönetim kurulu üyesi | 17 Kasım 2025 A | 304 | 0 | 0 | $0 |
| Karen Walker | Yönetim kurulu üyesi | 18 Kasım 2024 A | 6.249 | 0 | 0 | $0 |
| Marschall S Runge | Yönetim kurulu üyesi | 20 Kasım 2023 A | 16.593 | 0 | 0 | $0 |
| Jackson P Tai | Yönetim kurulu üyesi | 17 Nisan 2023 A | 63.524 | 0 | 0 | $0 |
| Michael L Eskew | Yönetim kurulu üyesi | 15 Kasım 2021 A | 45.080 | 0 | 0 | $0 |
| Carolyn R Bertozzi | Yönetim kurulu üyesi | 16 Kasım 2020 A | 6.243 | 0 | 0 | $0 |
| Kathi P Seifert | Yönetim kurulu üyesi | 16 Kasım 2020 A | 77.038 | 0 | 0 | $0 |
| Ellen R Marram | Yönetim kurulu üyesi | 15 Nisan 2019 A | 56.645 | 0 | 0 | $0 |
| Franklyn G Prendergast | Yönetim kurulu üyesi | 20 Kasım 2017 A | 68.574 | 0 | 0 | $0 |
| David R Hoover | Yönetim kurulu üyesi | 20 Kasım 2017 A | 36.284 | 0 | 0 | $0 |
| Karen N Horn | Yönetim kurulu üyesi | 30 Kasım 2015 A | 73.166 | 0 | 0 | $0 |
| Douglas R Oberhelman | Yönetim kurulu üyesi | 28 Kasım 2014 A | 22.675 | 0 | 0 | $0 |
| Alfred G Gilman | Yönetim kurulu üyesi | 29 Kasım 2013 A | 48.287 | 0 | 0 | $0 |
| Winfried F W Sir Bischoff | Yönetim kurulu üyesi | 29 Kasım 2013 A | 42.444 | 0 | 0 | $0 |
| Martin S Feldstein | Yönetim kurulu üyesi | 30 Kasım 2011 A | 30.733 | 0 | 0 | $0 |
| Michael J Cook | Yönetim kurulu üyesi | 28 Kasım 2008 A | 17.337 | 0 | 0 | $0 |
| George M C Fisher | Yönetim kurulu üyesi | 30 Nisan 2008 A | 28.942 | 0 | 0 | $0 |
| John Sir Rose | Yönetim kurulu üyesi | 31 Aralık 2004 A | 1.689 | 0 | 0 | $0 |
| Steven C Beering | Yönetim kurulu üyesi | 30 Kasım 2004 A | 27.760 | 0 | 0 | $0 |
| Eli Lilly and Company | 10% sahip | 08 Şubat 2005 C | 300.340 | 0 | 0 | $0 |
| Donald A Zakrowski | · | 10 Ağustos 2026 S | 1.526 | 0 | 2 | $-3.380.520 |
| LILLY ENDOWMENT INC | · | 06 Mayıs 2026 S | 91.881.150 | 0 | 302 | $-3.081.260.798 |
| Mary Lynne Hedley | · | 15 Aralık 2025 A | 2.253 | 0 | 0 | $0 |
| Aarti S. Shah | · | 08 Şubat 2021 A | 31.622 | 0 | 0 | $0 |
| Joshua L Smiley | · | 08 Şubat 2021 A | 77.659 | 0 | 0 | $0 |
| John C Lechleiter | · | 25 Mayıs 2017 G | 436.160 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 211 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IHE · iShares Trust | 20,85% | 300.758 SH | 11 Eylül 2026 | Günlük |
| MEDI · Harbor ETF Trust | 20,78% | 7.455 NS | 31 Temmuz 2026 | N-PORT |
| ELIL · Direxion Shares ETF Trust | 15,09% | 2.399 NS | 31 Temmuz 2026 | N-PORT |
| IYH · iShares Trust | 14,44% | 467.326 SH | 11 Eylül 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 14,19% | 2.414.193 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 13,35% | 382.033 NS | 31 Temmuz 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 10,41% | 15.566 NS | 31 Temmuz 2026 | N-PORT |
| IXJ · iShares Trust | 10,00% | 369.457 SH | 11 Eylül 2026 | Günlük |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 7,76% | 613 NS | 31 Temmuz 2026 | N-PORT |
| CARK · Advisors' Inner Circle Fund II | 5,46% | 15.162 NS | 31 Temmuz 2026 | N-PORT |
| PJP · Invesco Exchange-Traded Fund Trust | 5,27% | 25.418 SH | 01 Ekim 2026 | Günlük |
| DUHP · Dimensional ETF Trust | 5,06% | 540.612 NS | 31 Temmuz 2026 | N-PORT |
| ARKG · ARK ETF Trust | 4,68% | 63.502 NS | 31 Temmuz 2026 | N-PORT |
| BKCG · BNY Mellon ETF Trust II | 4,61% | 4.808 NS | 31 Temmuz 2026 | N-PORT |
| SEMG · EA Series Trust | 4,59% | 2.496 NS | 31 Temmuz 2026 | N-PORT |
| FLAG · Global X Funds | 4,40% | 65 NS | 31 Temmuz 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 4,27% | 1.568 NS | 31 Temmuz 2026 | N-PORT |
| LRND · New York Life Investments ETF Trust | 4,23% | 14.677 NS | 31 Temmuz 2026 | N-PORT |
| QUSA · Tidal Trust III | 4,22% | 789 NS | 31 Temmuz 2026 | N-PORT |
| WINN · Harbor ETF Trust | 4,16% | 40.899 NS | 31 Temmuz 2026 | N-PORT |
| HFGO · Hartford Funds Exchange-Traded Trust | 4,15% | 7.258 NS | 31 Temmuz 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 4,14% | 4.469.091 SH | 19 Ağustos 2026 | Günlük |
| GDIV · Harbor ETF Trust | 4,12% | 8.445 NS | 31 Temmuz 2026 | N-PORT |
| NULG · Nushares ETF Trust | 4,10% | 95.153 NS | 31 Temmuz 2026 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 4,03% | 26.813 SH | 01 Ekim 2026 | Günlük |
| NUGO · Nushares ETF Trust | 3,95% | 83.920 NS | 31 Temmuz 2026 | N-PORT |
| XT · iShares Trust | 3,90% | 134.688 SH | 11 Eylül 2026 | Günlük |
| QUAL · iShares Trust | 3,62% | 1.501.440 SH | 11 Eylül 2026 | Günlük |
| ESGG · FlexShares Trust | 3,59% | 3.458 NS | 31 Temmuz 2026 | N-PORT |
| TOPT · iShares Trust | 3,55% | 21.175 SH | 11 Eylül 2026 | Günlük |
| JXX · Janus Detroit Street Trust | 3,51% | 815 NS | 31 Temmuz 2026 | N-PORT |
| WLTG · ETF Opportunities Trust | 3,50% | 2.343 NS | 31 Temmuz 2026 | N-PORT |
| ESG · FlexShares Trust | 3,42% | 3.930 NS | 31 Temmuz 2026 | N-PORT |
| MGK · VANGUARD WORLD FUND | 3,39% | 943.950 SH | 19 Ağustos 2026 | Günlük |
| FFLG · FIDELITY COVINGTON TRUST | 3,34% | 17.155 NS | 31 Temmuz 2026 | N-PORT |
| IWY · iShares Trust | 3,21% | 445.776 SH | 11 Eylül 2026 | Günlük |
| PABU · iShares Trust | 3,19% | 70.945 SH | 11 Eylül 2026 | Günlük |
| SAWG · ETF Series Solutions | 3,03% | 76 NS | 31 Temmuz 2026 | N-PORT |
| HGRO · ETF Opportunities Trust | 3,01% | 3.308 NS | 31 Temmuz 2026 | N-PORT |
| PWB · Invesco Exchange-Traded Fund Trust | 3,00% | 70.318 SH | 01 Ekim 2026 | Günlük |
| IWFG · New York Life Investments Active ET… | 2,99% | 1.578 NS | 31 Temmuz 2026 | N-PORT |
| IWLG · New York Life Investments Active ET… | 2,96% | 8.027 NS | 31 Temmuz 2026 | N-PORT |
| ABFL · Abacus FCF ETF Trust | 2,96% | 13.534 NS | 31 Temmuz 2026 | N-PORT |
| BDIV · ETF Series Solutions | 2,93% | 170 NS | 31 Temmuz 2026 | N-PORT |
| AQLT · iShares Trust | 2,83% | 8.223 SH | 11 Eylül 2026 | Günlük |
| VONG · VANGUARD SCOTTSDALE FUNDS | 2,83% | 1.264.079 SH | 19 Ağustos 2026 | Günlük |
| ILCG · iShares Trust | 2,82% | 78.015 SH | 11 Eylül 2026 | Günlük |
| VUG · VANGUARD INDEX FUNDS | 2,80% | 8.865.142 SH | 19 Ağustos 2026 | Günlük |
| ESLG · Strategy Shares | 2,77% | 560 NS | 31 Temmuz 2026 | N-PORT |
| CCOR · Listed Funds Trust | 2,75% | 668 NS | 31 Temmuz 2026 | N-PORT |
| IWF · iShares Trust | 2,72% | 3.000.603 SH | 11 Eylül 2026 | Günlük |
| FBCG · FIDELITY COVINGTON TRUST | 2,71% | 163.157 NS | 31 Temmuz 2026 | N-PORT |
| WRND · New York Life Investments ETF Trust | 2,70% | 245 NS | 31 Temmuz 2026 | N-PORT |
| VOOG · VANGUARD ADMIRAL FUNDS | 2,67% | 587.806 SH | 19 Ağustos 2026 | Günlük |
| SUSL · iShares Trust | 2,64% | 28.252 SH | 11 Eylül 2026 | Günlük |
| MPLY · Strategy Shares | 2,61% | 361 NS | 31 Temmuz 2026 | N-PORT |
| EGUS · iShares Trust | 2,59% | 637 SH | 11 Eylül 2026 | Günlük |
| ALRG · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 2,55% | 186 NS | 31 Temmuz 2026 | N-PORT |
| IVW · iShares Trust | 2,49% | 1.687.144 SH | 11 Eylül 2026 | Günlük |
| HAPI · Harbor ETF Trust | 2,41% | 10.281 NS | 31 Temmuz 2026 | N-PORT |
| IUSG · iShares Trust | 2,37% | 696.466 SH | 11 Eylül 2026 | Günlük |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 2,20% | 2.157 NS | 31 Temmuz 2026 | N-PORT |
| XLG · Invesco Exchange-Traded Fund Trust | 2,19% | 221.240 SH | 01 Ekim 2026 | Günlük |
| IOO · iShares Trust | 2,15% | 173.119 SH | 11 Eylül 2026 | Günlük |
| EGLE · Global X Funds | 2,10% | 40 NS | 31 Temmuz 2026 | N-PORT |
| BIGY · Tidal Trust II | 2,02% | 958 NS | 31 Temmuz 2026 | N-PORT |
| FDRR · FIDELITY COVINGTON TRUST | 1,98% | 12.722 NS | 31 Temmuz 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 1,97% | 844 NS | 31 Temmuz 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 1,96% | 15.409 NS | 31 Temmuz 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,95% | 34.285 SH | 01 Ekim 2026 | Günlük |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 1,94% | 79.178 SH | 01 Ekim 2026 | Günlük |
| MGC · VANGUARD WORLD FUND | 1,92% | 169.440 SH | 19 Ağustos 2026 | Günlük |
| CAML · Professionally Managed Portfolios | 1,90% | 6.102 NS | 31 Temmuz 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,89% | 34 NS | 31 Temmuz 2026 | N-PORT |
| OEF · iShares Trust | 1,86% | 334.432 SH | 11 Eylül 2026 | Günlük |
| INFO · Harbor ETF Trust | 1,83% | 13.459 NS | 31 Temmuz 2026 | N-PORT |
| LGDX · Tidal Trust III | 1,81% | 2.243 NS | 31 Temmuz 2026 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 1,80% | 22.333 NS | 31 Temmuz 2026 | N-PORT |
| OEI · Listed Funds Trust | 1,78% | 716 NS | 31 Temmuz 2026 | N-PORT |
| FQAL · FIDELITY COVINGTON TRUST | 1,77% | 21.731 NS | 31 Temmuz 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 1,76% | 20.353 NS | 31 Temmuz 2026 | N-PORT |
| USCL · iShares Trust | 1,68% | 42.370 SH | 11 Eylül 2026 | Günlük |
| RPG · Invesco Exchange-Traded Fund Trust | 1,68% | 27.963 SH | 01 Ekim 2026 | Günlük |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,68% | 12.676 SH | 01 Ekim 2026 | Günlük |
| ACVF · ETF Opportunities Trust | 1,67% | 2.219 NS | 31 Temmuz 2026 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 1,67% | 17.434 NS | 31 Temmuz 2026 | N-PORT |
| TOPC · iShares Trust | 1,64% | 480 SH | 11 Eylül 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 1,64% | 180.485 SH | 19 Ağustos 2026 | Günlük |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,62% | 14.775 NS | 31 Temmuz 2026 | N-PORT |
| VV · VANGUARD INDEX FUNDS | 1,61% | 989.866 SH | 19 Ağustos 2026 | Günlük |
| FYEE · Fidelity Greenwood Street Trust | 1,61% | 3.053 NS | 31 Temmuz 2026 | N-PORT |
| FHEQ · Fidelity Greenwood Street Trust | 1,61% | 12.988 NS | 31 Temmuz 2026 | N-PORT |
| IWL · iShares Trust | 1,59% | 31.019 SH | 11 Eylül 2026 | Günlük |
| QVML · Invesco Exchange-Traded Fund Trust … | 1,59% | 22.795 SH | 01 Ekim 2026 | Günlük |
| ESUM · Strategy Shares | 1,58% | 2.498 NS | 31 Temmuz 2026 | N-PORT |
| BOBP · EXCHANGE TRADED CONCEPTS TRUST | 1,57% | 8 NS | 31 Temmuz 2026 | N-PORT |
| TOV · EA Series Trust | 1,54% | 3.526 NS | 31 Temmuz 2026 | N-PORT |
| FBUF · Fidelity Greenwood Street Trust | 1,54% | 320 NS | 31 Temmuz 2026 | N-PORT |
| QLV · FlexShares Trust | 1,53% | 2.184 NS | 31 Temmuz 2026 | N-PORT |
| GARP · iShares Trust | 1,53% | 41.621 SH | 11 Eylül 2026 | Günlük |
| XVV · iShares Trust | 1,52% | 9.102 SH | 11 Eylül 2026 | Günlük |
| BKLC · BNY Mellon ETF Trust | 1,50% | 71.304 NS | 31 Temmuz 2026 | N-PORT |
| RGEF · Tidal Trust III | 1,48% | 10.487 NS | 31 Temmuz 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 1,47% | 20.548.671 SH | 19 Ağustos 2026 | Günlük |
| ACIO · ETF Series Solutions | 1,44% | 29.402 NS | 31 Temmuz 2026 | N-PORT |
| ADME · ETF Series Solutions | 1,43% | 3.659 NS | 31 Temmuz 2026 | N-PORT |
| XYLD · Global X Funds | 1,43% | 40.272 NS | 31 Temmuz 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 1,43% | 110.455 NS | 31 Temmuz 2026 | N-PORT |
| XRMI · Global X Funds | 1,42% | 619 NS | 31 Temmuz 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 1,42% | 4.759 SH | 01 Ekim 2026 | Günlük |
| VOTE · TCW ETF Trust | 1,42% | 13.544 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 1,41% | 27.982 NS | 31 Temmuz 2026 | N-PORT |
| XYLG · Global X Funds | 1,41% | 788 NS | 31 Temmuz 2026 | N-PORT |
| XTR · Global X Funds | 1,41% | 59 NS | 31 Temmuz 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 1,41% | 39.998 NS | 31 Temmuz 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 1,40% | 138.025 SH | 01 Ekim 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 1,40% | 26.912.148 SH | 19 Ağustos 2026 | Günlük |
| VFQY · VANGUARD WELLINGTON FUND | 1,39% | 5.519 SH | 19 Ağustos 2026 | Günlük |
| XCLR · Global X Funds | 1,38% | 43 NS | 31 Temmuz 2026 | N-PORT |
| VONE · VANGUARD SCOTTSDALE FUNDS | 1,38% | 131.995 SH | 19 Ağustos 2026 | Günlük |
| SUSA · iShares Trust | 1,37% | 49.063 SH | 11 Eylül 2026 | Günlük |
| VOXP · Advisors Series Trust | 1,37% | 69 NS | 31 Temmuz 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 1,36% | 1.152 NS | 31 Temmuz 2026 | N-PORT |
| ILCB · iShares Trust | 1,36% | 15.558 SH | 11 Eylül 2026 | Günlük |
| IVV · iShares Trust | 1,36% | 9.970.768 SH | 11 Eylül 2026 | Günlük |
| ESGU · iShares Trust | 1,34% | 213.953 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 1,33% | 242.484 NS | 31 Temmuz 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 1,32% | 2.079 NS | 31 Temmuz 2026 | N-PORT |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 1,32% | 67.225 SH | 19 Ağustos 2026 | Günlük |
| SPUU · Direxion Shares ETF Trust | 1,30% | 2.984 NS | 31 Temmuz 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 1,28% | 19.058 NS | 31 Temmuz 2026 | N-PORT |
| IWB · iShares Trust | 1,28% | 552.647 SH | 11 Eylül 2026 | Günlük |
| IYY · iShares Trust | 1,27% | 33.929 SH | 11 Eylül 2026 | Günlük |
| GURU · Global X Funds | 1,27% | 675 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 1,24% | 134.114 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 1,23% | 220.052 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 1,21% | 1.029.891 SH | 11 Eylül 2026 | Günlük |
| PHDG · Invesco Actively Managed Exchange-T… | 1,18% | 630 SH | 01 Ekim 2026 | Günlük |
| DGRO · iShares Trust | 1,17% | 448.248 SH | 11 Eylül 2026 | Günlük |
| DYNF · BlackRock ETF Trust | 1,17% | 432.252 SH | 11 Eylül 2026 | Günlük |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 1,16% | 46.812 NS | 31 Temmuz 2026 | N-PORT |
| JHAI · Janus Detroit Street Trust | 1,16% | 236 NS | 31 Temmuz 2026 | N-PORT |
| ESLV · Strategy Shares | 1,15% | 143 NS | 31 Temmuz 2026 | N-PORT |
| UPSD · ETF Series Solutions | 1,15% | 1.172 NS | 31 Temmuz 2026 | N-PORT |
| LRGF · iShares Trust | 1,15% | 37.655 SH | 11 Eylül 2026 | Günlük |
| PEVC · Pacer Funds Trust | 1,15% | 24 NS | 31 Temmuz 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,15% | 206 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 1,12% | 32.698 NS | 31 Temmuz 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 1,12% | 5.503 NS | 31 Temmuz 2026 | N-PORT |
| QLC · FlexShares Trust | 1,12% | 9.856 NS | 31 Temmuz 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 1,06% | 61.844 NS | 31 Temmuz 2026 | N-PORT |
| TOK · iShares Trust | 1,05% | 2.227 SH | 11 Eylül 2026 | Günlük |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,05% | 25.050 SH | 01 Ekim 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 1,05% | 436.319 NS | 31 Temmuz 2026 | N-PORT |
| URTH · iShares, Inc. | 0,99% | 72.189 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,95% | 18.012 NS | 31 Temmuz 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,91% | 19.799 NS | 31 Temmuz 2026 | N-PORT |
| CRBN · iShares Trust | 0,87% | 9.092 SH | 11 Eylül 2026 | Günlük |
| ACWI · iShares Trust | 0,87% | 255.406 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,86% | 4.138 NS | 31 Temmuz 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,84% | 1.484 NS | 31 Temmuz 2026 | N-PORT |
| QDEF · FlexShares Trust | 0,83% | 3.936 NS | 31 Temmuz 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,82% | 668.115 SH | 19 Ağustos 2026 | Günlük |
| AAAA · EA Series Trust | 0,82% | 1.994 NS | 31 Temmuz 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,82% | 24.661.000 | 01 Ekim 2026 | Günlük |
| GRZZ · Tidal Trust II | 0,79% | 229 NS | 31 Temmuz 2026 | N-PORT |
| GLOF · iShares Trust | 0,79% | 1.409 SH | 11 Eylül 2026 | Günlük |
| USMV · iShares Trust | 0,76% | 161.533 SH | 11 Eylül 2026 | Günlük |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,75% | 8.571 NS | 31 Temmuz 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,74% | 1.573 NS | 31 Temmuz 2026 | N-PORT |
| ESMV · iShares Trust | 0,74% | 51 SH | 11 Eylül 2026 | Günlük |
| QDF · FlexShares Trust | 0,71% | 13.678 NS | 31 Temmuz 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,69% | 92 NS | 31 Temmuz 2026 | N-PORT |
| FDVV · FIDELITY COVINGTON TRUST | 0,65% | 57.451 NS | 31 Temmuz 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,61% | 165.000 | 01 Ekim 2026 | Günlük |
| ARKK · ARK ETF Trust | 0,59% | 28.416 NS | 31 Temmuz 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,56% | 550 NS | 31 Temmuz 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,49% | 22.531.000 | 01 Ekim 2026 | Günlük |
| PALC · Pacer Funds Trust | 0,48% | 879 NS | 31 Temmuz 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,46% | 16.167.000 | 01 Ekim 2026 | Günlük |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,46% | 3.786 SH | 01 Ekim 2026 | Günlük |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,42% | 35.332 SH | 01 Ekim 2026 | Günlük |
| VMAX · Lattice Strategies Trust | 0,38% | 161 NS | 31 Temmuz 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,37% | 1.864 NS | 31 Temmuz 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,35% | 461.000 | 01 Ekim 2026 | Günlük |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,34% | 4.699 NS | 31 Temmuz 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,34% | 9.325.000 | 01 Ekim 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,32% | 27.149 SH | 01 Ekim 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,28% | 4.741 SH | 19 Ağustos 2026 | Günlük |
| ROUS · Lattice Strategies Trust | 0,26% | 1.624 NS | 31 Temmuz 2026 | N-PORT |
| DFVX · Dimensional ETF Trust | 0,24% | 1.098 NS | 31 Temmuz 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 174.142 SH | 01 Ekim 2026 | Günlük |
| SIZE · iShares Trust | 0,18% | 701 SH | 11 Eylül 2026 | Günlük |
| EUSA · iShares, Inc. | 0,18% | 3.047 SH | 11 Eylül 2026 | Günlük |
| ACWV · iShares, Inc. | 0,17% | 5.195 SH | 11 Eylül 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 669 SH | 01 Ekim 2026 | Günlük |
| NEAR · iShares U.S. ETF Trust | 0,09% | 4.790.000 SH | 11 Eylül 2026 | Günlük |
| GTOS · Invesco Actively Managed Exchange-T… | 0,09% | 106.000 | 01 Ekim 2026 | Günlük |
| GTO · Invesco Actively Managed Exchange-T… | 0,07% | 2.025.800 | 01 Ekim 2026 | Günlük |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDX · VANGUARD CHARLOTTE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Temmuz 2026 | Günlük |
LLY Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 38 analist
AL
Medyan hedef
$1385.00
+21,2%
11 28,9%
Güçlü Al
19 50,0%
Al
7 18,4%
Tut
1 2,6%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
29 analist · 2026-10-03Ortalama hedef $1328.83 +16,3%
Şimdi
Mevcut fiyat $1142.85
Düşük$930.00
Ortalama$1328.83
Yüksek$1600.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
| JNJ | · | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| MRK | · | 14.5 | 1.3% | 28.1% | 36.9% | · |
| PFE | · | 18.3 | -1.7% | 12.4% | 8.9% | · |
| BMY | · | 15.6 | -0.22% | 14.6% | 40.5% | · |
| RPRX | · | 21.7 | 5.1% | 32.4% | 8.0% | · |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
Son Haberler Bu şirketten bahseden son manşetler
GLP-1 sonrası yeni nesil obezite ilaçları için Lilly ve Novo'nun amilin bahisleri
CNBC · 23 saat, 29 dakika önce
Lilly's Foundayo Outperforms Oral Semaglutide In New Diabetes Analysis
Nasdaq · 4 gün, 8 saat önce
Eli Lilly Just Announced Game-Changing News
Nasdaq · 5 gün, 7 saat önce
Novo Nordisk'in Bir Sonraki Milyar Dolarlık Kilo Verme Ürünü Bu Olabilir mi?
Nasdaq · 1 hafta önce
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
CNBC · 1 hafta, 1 gün önce
Could Retatrutide Be Worth $10 Billion to Eli Lilly?
Nasdaq · 1 hafta, 2 gün önce
Eli Lilly vs. Novo: The Obesity-Drug Battle Is Entering Its Next Round
Yahoo Finance · 1 hafta, 3 gün önce
Why Novo Nordisk Stock Just Crashed
Nasdaq · 1 hafta, 4 gün önce
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
CNBC · 1 hafta, 4 gün önce
Three Center-Stage AI Players Join Eli Lilly On Elite Screen
Yahoo Finance · 1 ay, 2 hafta önce
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Canlı sinyal — ekrandaki tek dolu kart.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026